Physician profile
Vikas A Shevade
NPI 1821200163
$350.95
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $272 · 2020: $47.41 · 2024: $31.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $31.13.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $31.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $113.56 | 2019 | |
| Ucb, INC. | $65.67 | 2019-2020 | |
| Merz North America, INC. | $37.90 | 2019 | |
| Adamas Pharmaceuticals, INC. | $32.59 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $31.13 | 2024 | Opdivo |
| Acadia Pharmaceuticals INC | $30.83 | 2019 | |
| Greenwich Biosciences, INC. | $24.48 | 2019 | |
| Alexion Pharmaceuticals, INC. | $14.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vikas Shevade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.